Evaluation of Single and Combined Temozolomide and Doxorubicin Treatment Responses in Low- and High-Grade Glioma In Vitro
The current data suggest that both TMZ and DOXO exhibit efficient therapeutic effects on low- and high-grade glioma cells. However, no synergistic effect was observed for combined therapy.
Authors
- Ştefana Oana Popescu
- Edmond Nicolae Barcan (ORCID: https://orcid.org/0000-0002-2744-5638)
- Veronica Sfredel
- Suzana Dănoiu (ORCID: https://orcid.org/0000-0003-0785-0123)
- Ligia Gabriela Tătăranu (ORCID: https://orcid.org/0000-0001-6788-5833)
- Daniela Elise Tache (ORCID: https://orcid.org/0000-0001-9083-5367)
- Stefania Carina Baloi
- Georgiana Adeline Staicu
- Anica Dricu (ORCID: https://orcid.org/0000-0002-3039-857X)
- Stefan Alexandru Artene
Institutions
- Carol Davila University of Medicine and Pharmacy (RO)
- Clinical Emergency Hospital Bucharest (RO)
- University of Medicine and Pharmacy of Craiova (RO)
- Czech Academy of Sciences, Institute of Physiology (CZ)
- University of Craiova (RO)
Publication Details
- Journal
- Cureus
- Published
- 2024-08-15
- DOI
- https://doi.org/10.7759/cureus.66928
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Unitatea Executiva pentru Finantarea Invatamantului Superior, a Cercetarii, Dezvoltarii si Inovarii